LIVN

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About LivaNova PLC

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide.
CEO
Damien McDonald
Employees
4000
Headquarters

20 Eastbourne Terrace, London W2 6LG
Phone: 442033250662
www.livanova.com

News

Livanova PT Lowered to $73 at Goldman Sachs
Aug 16, 2022 07:45am

https://www.investing.com/news/pro/livanova-pt-lowered-to-73-at-goldman-sachs-432SI-2873260


Source:Investing.com
P2 Capital Partners, LLC Buys 2, Sells 3 in 2nd Quarter
Aug 16, 2022 01:00am

Related Stocks: CDK , BLKB , LIVN , OUT , NXST ,


Source:GuruFocus
LivaNova''s Return on Invested Capital Overview
Aug 10, 2022 14:04pm

According to Benzinga Pro, during Q2, LivaNova (NASDAQ: LIVN ) earned $16.44 million, a 449.42% increase from the preceding quarter. LivaNova also posted a total of $254.20 million in sales, a 5.83% increase since Q1. LivaNova earned $2.99 million, and sales totaled $240.20 million in Q1. What Is Return On Invested Capital? Earnings data without context is not clear and can difficult to base trading decisions on. Return on Invested Capital (ROIC) helps to filter signal from noise by measuring yearly pre-tax profit relative to invested capital by a business. Generally, a higher ROIC suggests … Full story available on Benzinga.com


Source:Benzinga
LivaNova PLC (LIVN) CEO Damien McDonald on Q2 2022 Results - Earnings Call Transcript
Aug 07, 2022 01:46am

LivaNova PLC (NASDAQ:NASDAQ:LIVN) Q2 2022 Earnings Conference Call August 03, 2022, 08:00 ET Company Participants Matthew Dodds - SVP, Corporate Development Damien McDonald - CEO &…


Source:Seeking Alpha
LivaNova PLC 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:LIVN)
Aug 07, 2022 01:09am

The following slide deck was published by LivaNova PLC in conjunction with their 2022 Q2 earnings call.


Source:Seeking Alpha
LivaNova: Value Gap To The Downside, Rate Neutral (NASDAQ:LIVN)
Aug 04, 2022 14:30pm

LivaNova printed Q2 FY22 earnings this week with upsides in revenue and EPS versus consensus. Click here to read our analysis of the stock.


Source:Seeking Alpha
Livanova PT Lowered to $80 at Wolfe Research
Aug 03, 2022 21:40pm

https://www.investing.com/news/pro/livanova-pt-lowered-to-80-at-wolfe-research-432SI-2862654


Source:Investing.com
Recap: LivaNova Q2 Earnings
Aug 03, 2022 11:49am

LivaNova (NASDAQ: LIVN ) reported its Q2 earnings results on Wednesday, August 3, 2022 at 06:00 AM. Here''s what investors need to know about the announcement. Earnings LivaNova beat estimated earnings by 1.92%, reporting an EPS of $0.53 versus an … Full story available on Benzinga.com


Source:Benzinga
LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03, 2022 10:12am

LivaNova PLC press release (LIVN): Q2 Non-GAAP EPS of $0.53 beats by $0.01.Revenue of $254.2M (-3.9% Y/Y) beats by $4.65M.Updated Full-Year 2022 OutlookLivaNova now expects revenue…


Source:Seeking Alpha
LivaNova Reports Second-Quarter 2022 Results
Aug 03, 2022 10:00am

LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova PLC, a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2022.


Source:Business Wire
Needham Remains Bullish On UK-Based MedTech Stock Citing Upcoming Catalyst
Jul 25, 2022 18:24pm

LivaNova PLC (NASDAQ: LIVN ) could provide an update on its RECOVER difficult-to-treat depression (DTD) trial within the next few months, representing a significant catalyst. Unipolar enrollment in the trial is approaching 325-350 patients, which management has indicated is the "sweet spot" where the trial could meet its endpoint. Needham believes that LIVN shares could increase by ~25-35% from ~$60 to ~$75-80 immediately after a positive disclosure and continue to increase in the following weeks. But the … Full story available on Benzinga.com


Source:Benzinga
Neuroprosthetics Market to Grow Huge Growth Rate by Forecast 2022 to 2032 | Livanova, Second Sight, Med-El, Retina Implant
Jul 12, 2022 12:27pm

The Global Neuroprosthetics Market research report is exhaustive research that provides dynamic and statistical insights into regional and global markets. It includes a comprehensive study of the current scenario to safeguard the trends and prospects of the market. Neuroprosthetics research reports also track future


Source:OpenPR
GSK to invest £1 billion on infectious disease research
Jun 23, 2022 00:00am

GSK plc (NYSE:GSK) has announced its plans to spend £1 billion over the next ten years on R&D focused on infectious diseases that disproportionately affect lower-income countries. Diseases covered in the research will include malaria, tuberculosis, HIV, neglected tropical diseases (NTDs) and antimicrobial resistance (AMR). The HIV focus will be through ViiV Healthcare, a joint…


Source:WTWH
Global Neurology Devices Market Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F
Jun 22, 2022 10:15am

DUBLIN , June 22, 2022 /PRNewswire/ -- The "Global Neurology Devices Market Report 2022" report has been added to ResearchAndMarkets.com''s offering. The global neurology devices market is expected to grow from $13.94 billion in 2021 to $15.91 billion in 2022 at a compound annual growth rate (CAGR) of 14.2%. The market is expected to grow to $25.75 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. Major companies in the neurology devices market include Medtronic Inc., Stryker Corporation, Terumo Corporation, Integra Lifesciences, Boston Scientific Corporation, Penumbra, Inc., B. Braun Group, Nevro, LivaNova, PLC, and Natus Medical. The neurology devices market consists of sales of neurology devices and related services by entities (organizations, sole traders, and partnerships) that produce neurology devices to diagnose and treat neurological diseases. The main types of neurology devices are cerebrospinal fluid management (CSF) devices and equipment, interventional neurology devices and equipment, neurosurgery devices and equipment, and neurostimulation devices.


Source:Benzinga
WAGO combines PLC and remote I/O into compact controller
Jun 22, 2022 00:00am

WAGO’s new Compact Controller 100 is a small-scale PLC with a wide variety of remote I/O for use in smaller applications. Engineered for OEMs, IIOT digitization projects, and building automation applications, this easy-to-use device is cost-effective for small, but demanding applications. This PLC can interface with industrial devices using protocols such as MODBUS TCP/UDP, EtherNet/IP,…


Source:WTWH
Edge AIoT Platform carries 12th Gen Intel Core Processors
Jun 22, 2022 00:00am

As global adoption of Edge AI continues, ASRock Industrial has released its new iEPF-9010S/iEP-9010E Series Robust Edge AIoT Platform, enabled by 12th Gen Intel Core Processors (Alder Lake S) with R680E/H610 chipsets to bring breakthrough performance at the Edge. Featuring excellent computing power with energized Edge AI acceleration, the iEPF-9010S/iEP-9010E Series provides high-memory capacity, rich […]


Source:WTWH